Sławomir Żegleń, Adam Nagajewski, Dominik Górski, Jacek Wojarski, William Karlsen, Lin Akily, Fanny Sunesson, Marcin Sawczuk, Rafał Nojek, Karolina Lipka, Marta Gallas, Anna Dukat-Mazurek, Wojtek Karolak
BACKGROUND: Patients undergoing lung transplantation are routinely managed with lifelong immunosuppression, which is associated with a heightened risk for infections. This study delves into the therapeutic challenges and strategies for managing lung transplant recipients (LTRs) infected with COVID-19 during long-term follow-up. METHODS: The was a case series analysis, among which nonstandard therapies consisting of targeted antibody treatment, antiviral drugs, or anti-interleukin-6 drugs were applied in patients after lung transplantation...
May 6, 2024: Transplantation Proceedings